Search results for "HIV infections"

showing 10 items of 304 documents

Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database.

2013

Background— We aimed to assess in-hospital case fatality and 1-year prognosis in HIV-infected patients with acute myocardial infarction. Methods and Results— From the PMSI (Program de Medicalisation des Systèmes d’informatique) database, data from 277 303 consecutive acute myocardial infarction patients hospitalized from January 1, 2005, to December 31, 2009, were analyzed. Surviving patients were followed up for 1 year after discharge. HIV-infected patients were compared with uninfected patients. Among the cohort, HIV-infected patients (n=608) accounted for 0.22%. All-cause hospital and 1-year mortality rates were lower in the HIV-infected group than in uninfected patients (3.1% versus 8.…

AdultMaleDatabases FactualStatistics as TopicMyocardial InfarctionHIV Infectionscomputer.software_genreCohort StudiesPhysiology (medical)Case fatality ratemedicineHumansMyocardial infarctionMedical Informatics ApplicationsAgedRetrospective StudiesAged 80 and overIschemic cardiomyopathyDatabasebusiness.industryMortality rateRetrospective cohort studyMiddle Agedmedicine.diseaseHospitalizationTreatment OutcomeCohortFemaleMyocardial infarction diagnosisFranceCardiology and Cardiovascular MedicinebusinesscomputerCohort studyCirculation
researchProduct

Factorial Structure and Psychometric Properties of a Brief Scale of the Condom Use Self-Efficacy for Spanish-Speaking People

2018

Background. Studies have shown the role played by perceived self-efficacy in explaining condom negotiation and condom use. Aims. The factorial structure and the psychometric properties of the Brief Condom Use Self-Efficacy Scale are presented. Method. The study included 368 men and 456 women aged 17 to 55 years ( Mage = 25.01, SD = 6.93). Results. Exploratory factor analysis yielded three factors: fear of rejection, impulse control, and condom acquisition and negotiation, which together accounted for 68% of the total variance. That structure was confirmed through confirmatory factor analysis. Cronbach’s alpha for the Brief Condom Use Self-Efficacy Scale was .71. The scale provided adequate…

AdultMaleFactorialPsychometricsAdolescentPsychometricsSpanish speakingHuman sexualityHIV InfectionsDevelopmental psychologylaw.inventionCondoms03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Acquired immunodeficiency syndrome (AIDS)CondomlawmedicineHumans030212 general & internal medicineCondom useSelf-efficacy030505 public healthPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseSelf EfficacyBrief measurePsychometric propertiesScale (social sciences)HIV/AIDSFemale0305 other medical sciencePsychologySelf-efficacy skills
researchProduct

Obtaining a male circumcision prevalence rate of 80% among adults in a short time

2017

Abstract World Health Organization recommends a target for the male circumcision prevalence rate of 80%. This rate will have a substantial impact on the human immunodeficiency virus-acquired immunodeficiency syndrome epidemic in Eastern and Southern Africa. The objective of the study was to assess whether an innovative intervention can lead to an increased voluntary male medical circumcision (VMMC) uptake among adults in a short time. This prospective observational study of a demand generation intervention was conducted in the township of Orange Farm (South Africa) in August to November 2015. In this community male circumcision prevalence rate among adults was stable between 2010 and 2015 a…

AdultMaleGerontologyHealth Knowledge Attitudes PracticeTime Factors4850AdolescentPopulationPsychological interventionPrevalenceObservational StudyDeveloping countryHIV InfectionsHealth PromotionMotivational InterviewingImmunodeficiency SyndromeSouth AfricaYoung Adult03 medical and health sciences0302 clinical medicinepreventionEnvironmental healthPrevalencemale circumcisionHumansMedicineProspective Studies030212 general & internal medicineYoung adultProspective cohort studyeducationeducation.field_of_study030505 public healthbusiness.industrypublic healthdemand creationHIVGeneral MedicineMiddle AgedPatient Acceptance of Health CareCircumcision MaleuptakeAfricaObservational study0305 other medical sciencebusinessResearch ArticleMedicine
researchProduct

Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.

2011

The objective of this study was to describe the prevalence of Hepatitis B virus (HBV), Hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections in a cohort of immigrants living in Palermo, Sicily. The study was carried out in the period May 2006-June 2010 and recruited a total of 393 patients (59.8% males-median age of 32.6 years). All patients were tested for serological markers of HBV, HCV, and HIV infection. One-hundred thirty-eight (35.1%) individuals did not show any HBV/HCV/HIV serological marker, while 186 (47.3%) were indicative of past or current HBV infection. A total of 42 (10.7%) subjects were HBsAg positive, 59 (15.0%) showed the serological profile "anti-HBc …

AdultMaleHBsAgmedicine.medical_specialtyHealth (social science)HIV AntigensHepatitis C virusEmigrants and ImmigrantsHIV InfectionsSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeEpidemiologymedicinePrevalenceHumansHuman immunodeficiencySicilyRetrospective StudiesHepatitis B virusHepatitis B Surface Antigensbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesHepatitis CHepatitis BMiddle Agedmedicine.diseaseHepatitis BVirologyHepatitis B Core AntigensHepatitis Cdigestive system diseasesCross-Sectional StudiesCohortFemalePublic HealthHepatitis C AntigensbusinessBiomarkersImmigrantJournal of community health
researchProduct

Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Ita…

2021

Sexually transmitted infections (STIs) are a serious global health problem. In Italy, data describing the vulnerability to STIs of specific sexual minorities and the influence of sociodemographic and behavioral determinants are limited, as most infections are not subject to mandatory notification. This retrospective study describes the sociodemographic profile and main sexual behaviors of patients attending a hospital in Palermo (Sicily, Italy) from January 2018 to March 2019 as predictors of STI risk. Patients were divided in subgroups: men-who-have-sex-with-men (MSM), men-who-have-sex-with-women (MSW), bisexual men and females. Data were obtained through an anonymous questionnaire. Patien…

AdultMaleHPVSexual BehaviorHealth Toxicology and MutagenesisSocio demographicsSexually Transmitted DiseasessyphilisHIV InfectionsMycoplasma genitaliumSTIsArticleSexual and Gender Minorities03 medical and health sciences0302 clinical medicineRisk FactorsmedicineGlobal healthHumansMycoplasma Infections030212 general & internal medicineMSMHomosexuality MaleSicilyDemographyRetrospective Studiesbehaviour risky factors HPV MSM STIs syphilis030505 public healthChlamydiabiologybusiness.industrybehaviour risky factorsPublic Health Environmental and Occupational HealthHPV infectionRvirus diseasesRetrospective cohort studymedicine.diseasebiology.organism_classificationHospitalsSexual PartnersSexual behaviorMedicineFemaleSyphilis0305 other medical sciencebusinessMycoplasma genitaliumDemography
researchProduct

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study

2010

To compare the management and the virological and serological efficacy of treatments for chronic hepatitis B (CHB) in HIV positive and negative patients.Two hundred and forty-six HIV positive and 205 HIV negative consecutive patients with past or present CHB, seen in October 2008 in participating departments, were included in a multicenter study. All the data were retrospectively collected from the first visit to October 2008 through a standardized questionnaire.Compared to HIV negative patients, HIV positive patients more often presented positive HBeAg (46.4% vs. 32.8%, p=0.01), HBV genotype A (54.8% vs. 17.1%, p0.0001), co-infection with HCV (12.4% vs. 5.9%, p=0.0002) or HDV (12.6% vs. 2.…

AdultMaleHepatitis B virusmedicine.medical_specialtyOrganophosphonatesHIV InfectionsAntiviral AgentsSerologyHepatitis B AntigensHepatitis B ChronicPharmacotherapyAcquired immunodeficiency syndrome (AIDS)Surveys and QuestionnairesInternal medicinemedicineHumansHepatitis B AntibodiesTenofovirSidaRetrospective StudiesHepatologybiologybusiness.industryAdeninevirus diseasesMiddle AgedHepatitis Bbiology.organism_classificationmedicine.diseaseHBeAgLentivirusImmunologyFemaleFranceViral diseasebusinessJournal of Hepatology
researchProduct

Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Stu…

2016

International audience;  Although an isolated anti-hepatitis B virus (HBV) core antibody (anti-HBc) serological profile is frequent in human immunodeficiency virus (HIV)-infected patients, data on HBV vaccination in these patients are scarce.  A prospective multicenter study was conducted to assess the immunogenicity of HBV vaccination in 54 patients with an isolated anti-HBc profile and undetectable HIV load. They were vaccinated with 1 dose (20 µg) of recombinant HBV vaccine. Those with an anti-HBV surface antibody (anti-HBs) level of 100 mIU/mL 4 weeks after a single recall dose of HBV vaccine should be further vaccinated with a reinforced triple double-dose scheme.

AdultMaleHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeVirusSerology03 medical and health sciences0302 clinical medicineImmunogenicity Vaccine[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyAntiretroviral Therapy Highly ActiveHepatitis B virus HBVImmunology and AllergyMedicineHumansHepatitis B Vaccines030212 general & internal medicineProspective StudiesHepatitis B AntibodiesProspective cohort study[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyVaccines Syntheticbiologybusiness.industryImmunogenicityvirus diseasesMiddle AgedHepatitis BVirologyHepatitis B Core Antigensdigestive system diseasesVaccinationInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyImmunologybiology.proteinHIV-1030211 gastroenterology & hepatologyFemaleAntibodybusiness
researchProduct

Validation of the German version of the ‘Hypogonadism Related Symptom Scale’ (HRS) in andrological patients with infertility, HIV infection and metab…

2013

Summary As commonly used self-reported screening instruments for male hypogonadism demonstrated lack of specificity, a Hypogonadism Related Symptom Scale (HRS) was developed in 2009 as a novel self-rating screening tool. As the questionnaire has not been validated, the purpose of our study was to perform a validation in patients presenting with different disorders (e.g. infertility, HIV infection or metabolic syndrome) and disease-related risk to develop hypogonadism. Two hundred and eighteen patients aged 19–71 years (40.1 ± 9.5) who completed the HRS and other common questionnaires [International Index Of Erectile Function (IIEF), National Institutes of Health Chronic Prostatitis Symptom …

AdultMaleInfertilitymedicine.medical_specialtyUrologyHuman immunodeficiency virus (HIV)ProstatitisHIV Infectionsmedicine.disease_causeHospital Anxiety and Depression ScaleSensitivity and SpecificitySeverity of Illness IndexYoung AdultEndocrinologyCronbach's alphaSex Hormone-Binding GlobulinSurveys and QuestionnairesInternal medicinemedicineHumansTestosteroneAgedMetabolic SyndromeGynecologybusiness.industryHypogonadismTestosterone (patch)General MedicineLuteinizing HormoneMiddle Agedmedicine.diseaseFollicle Stimulating HormoneSymptom AssessmentMetabolic syndromeLuteinizing hormonebusinessAndrologia
researchProduct

Dynamics and molecular evolution of HIV-1 strains in Sicily among antiretroviral naïve patients.

2012

Abstract HIV-1 subtype B is the most frequent strain in Sicily. To date, there is no available data about the genetic diversity of HIV-1 viral strains circulating in Sicily among antiretroviral (ARV) naive subjects and the role of immigration as potential determinant of evolutionary dynamics of HIV-1 molecular epidemiology. For this purpose, HIV-1 polymerase (pol) sequences obtained from 155 ARV naive individuals from 2004 to 2009 were phylogenetically analysed. The overall rate of HIV-1 non-B infections was 31.0% (n = 48/155), increasing from 7.8% in 2004–2006 to 40.9% in 2009, and about one-third were identified as unique recombinant forms. CRF02_AG was the prevalent non-B clade (n = 28/4…

AdultMaleMicrobiology (medical)AdolescentPopulationHIV Infectionsnon-B subtypeBiologySettore MED/42 - Igiene Generale E ApplicataMicrobiologyCohort StudiesEvolution MolecularMolecular evolutionGeneticsCluster AnalysisHumansHIV-1 subtypes; non-B subtypes; CRF; Molecular evolution; HAART-naïve patientsChildEvolutionary dynamicseducationCladeSicilyMolecular BiologyPhylogenyEcology Evolution Behavior and SystematicsAgedMolecular Epidemiologyeducation.field_of_studyGenetic diversityHIV-1 subtypeChi-Square DistributionMolecular epidemiologyPhylogenetic treeHAART-naïve patientsStrain (biology)Infantvirus diseasesCRFMiddle AgedGenes polVirologyInfectious DiseasesChild PreschoolHIV-1Molecular evolutionFemale
researchProduct

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010

2012

Prevalence and predictors of transmitted drug resistance (TDR), defined as the presence of at least one WHO surveillance drug resistance mutation (SDRM), were investigated in antiretroviral-naïve HIV-1-infected patients, with a genotypic resistance test (GRT) performed ≤6months before starting cART between 2000 and 2010. 3163 HIV-1 sequences were selected (69% subtype B). Overall, the prevalence of TDR was 12% (13.2% subtype B, 9% non-B). TDR significantly declined overall and for the single drug classes. Older age independently predicted increased odds of TDR, whereas a more recent GRT, a higher HIV-RNA and C vs. B subtype predicted lower odds of TDR. © 2012 The Authors. Clinical Microbiol…

AdultMaleMicrobiology (medical)CartDrugmedicine.medical_specialtyGenotypeAnti-HIV Agentsmedia_common.quotation_subjectHuman immunodeficiency virus (HIV)HIV InfectionsDrug resistancemedicine.disease_causeArticleEvolution Molecular03 medical and health sciencesrecent HIV infection0302 clinical medicineInternal medicineDrug Resistance ViralPrevalencemedicineHumansHIV Infection030212 general & internal medicinemedia_common0303 health scienceschronic HIV infection030306 microbiologybusiness.industryAntiretroviral therapy; Chronic HIV infection; Recent HIV infection; Resistance epidemiology; Transmitted resistance; Microbiology (medical); Infectious DiseasesAnti-HIV AgentGeneral MedicineMiddle Agedtransmitted resistanceVirologyAntiretroviral therapy3. Good healthAntiretroviral therapyInfectious DiseasesItalyHIV-1Genotypic resistanceFemalebusinessHumanresistance epidemiologyClinical Microbiology and Infection
researchProduct